Can adaptive trials change the way we treat Alzheimer's disease?
How are the world’s largest pharmaceutical companies adapting their R&D strategies to incorporate new technology that is putting the emphasis back on the patient?
Neuroscience, meet Donkey Kong. Can microprocessors help us understand inner workings of the brain?
It was another busy week for pharma, tech and smart data news. Catch up below, and stay in touch with us all week on Twitter and LinkedIn.
Read up on all of our news highlights from last week below.